The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tuberculosis Prevention and Treatment Vaccine Market Research Report 2025
Synopsis
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
The global Tuberculosis Prevention and Treatment Vaccine market was valued at US$ 74 million in 2023 and is anticipated to reach US$ 102 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Prevention and Treatment Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Prevention and Treatment Vaccine.
Report Scope
The Tuberculosis Prevention and Treatment Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Prevention and Treatment Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Prevention and Treatment Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Segment by Type
Immune Vaccine
Therapy Vaccine
Segment by Application
Self-Procurement
UNICEF
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tuberculosis Prevention and Treatment Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tuberculosis Prevention and Treatment Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
The global Tuberculosis Prevention and Treatment Vaccine market was valued at US$ 74 million in 2023 and is anticipated to reach US$ 102 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Prevention and Treatment Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Prevention and Treatment Vaccine.
Report Scope
The Tuberculosis Prevention and Treatment Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Prevention and Treatment Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Prevention and Treatment Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Segment by Type
Immune Vaccine
Therapy Vaccine
Segment by Application
Self-Procurement
UNICEF
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tuberculosis Prevention and Treatment Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tuberculosis Prevention and Treatment Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Tuberculosis Prevention and Treatment Vaccine Market Overview
1.1 Product Overview and Scope of Tuberculosis Prevention and Treatment Vaccine
1.2 Tuberculosis Prevention and Treatment Vaccine Segment by Type
1.2.1 Global Tuberculosis Prevention and Treatment Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Tuberculosis Prevention and Treatment Vaccine Segment by Application
1.3.1 Global Tuberculosis Prevention and Treatment Vaccine Market Value by Application: (2024-2030)
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Global Tuberculosis Prevention and Treatment Vaccine Market Size Estimates and Forecasts
1.4.1 Global Tuberculosis Prevention and Treatment Vaccine Revenue 2019-2030
1.4.2 Global Tuberculosis Prevention and Treatment Vaccine Sales 2019-2030
1.4.3 Global Tuberculosis Prevention and Treatment Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tuberculosis Prevention and Treatment Vaccine Market Competition by Manufacturers
2.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tuberculosis Prevention and Treatment Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Tuberculosis Prevention and Treatment Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tuberculosis Prevention and Treatment Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tuberculosis Prevention and Treatment Vaccine, Product Type & Application
2.7 Tuberculosis Prevention and Treatment Vaccine Market Competitive Situation and Trends
2.7.1 Tuberculosis Prevention and Treatment Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tuberculosis Prevention and Treatment Vaccine Players Market Share by Revenue
2.7.3 Global Tuberculosis Prevention and Treatment Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tuberculosis Prevention and Treatment Vaccine Retrospective Market Scenario by Region
3.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tuberculosis Prevention and Treatment Vaccine Global Tuberculosis Prevention and Treatment Vaccine Sales by Region: 2019-2030
3.2.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Region: 2019-2024
3.2.2 Global Tuberculosis Prevention and Treatment Vaccine Sales by Region: 2025-2030
3.3 Global Tuberculosis Prevention and Treatment Vaccine Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region: 2019-2030
3.3.1 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region: 2019-2024
3.3.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region: 2025-2030
3.4 North America Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
3.4.1 North America Tuberculosis Prevention and Treatment Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2019-2030)
3.4.3 North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
3.5.1 Europe Tuberculosis Prevention and Treatment Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2019-2030)
3.5.3 Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
3.7.1 Latin America Tuberculosis Prevention and Treatment Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2019-2030)
4.1.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2019-2024)
4.1.2 Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2025-2030)
4.1.3 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2019-2030)
4.2.1 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2019-2024)
4.2.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2025-2030)
4.2.3 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2019-2030)
5.1.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2019-2024)
5.1.2 Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2025-2030)
5.1.3 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2019-2030)
5.2.1 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2019-2024)
5.2.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2025-2030)
5.2.3 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Corporation Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Corporation Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Corporation Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 BioFarma
6.5.1 BioFarma Corporation Information
6.5.2 BioFarma Description and Business Overview
6.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BioFarma Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.5.5 BioFarma Recent Developments/Updates
6.6 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Corporation Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
6.7 China National Biotec
6.6.1 China National Biotec Corporation Information
6.6.2 China National Biotec Description and Business Overview
6.6.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.7.5 China National Biotec Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Corporation Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Corporation Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Ataulpho de Paiva
6.10.1 Ataulpho de Paiva Corporation Information
6.10.2 Ataulpho de Paiva Description and Business Overview
6.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.10.5 Ataulpho de Paiva Recent Developments/Updates
6.11 IVAC
6.11.1 IVAC Corporation Information
6.11.2 IVAC Tuberculosis Prevention and Treatment Vaccine Description and Business Overview
6.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 IVAC Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.11.5 IVAC Recent Developments/Updates
6.12 Queen Saovabha Mem. Inst
6.12.1 Queen Saovabha Mem. Inst Corporation Information
6.12.2 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Description and Business Overview
6.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
6.13 Microgen
6.13.1 Microgen Corporation Information
6.13.2 Microgen Tuberculosis Prevention and Treatment Vaccine Description and Business Overview
6.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Microgen Tuberculosis Prevention and Treatment Vaccine Product Portfolio
6.13.5 Microgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tuberculosis Prevention and Treatment Vaccine Industry Chain Analysis
7.2 Tuberculosis Prevention and Treatment Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tuberculosis Prevention and Treatment Vaccine Production Mode & Process
7.4 Tuberculosis Prevention and Treatment Vaccine Sales and Marketing
7.4.1 Tuberculosis Prevention and Treatment Vaccine Sales Channels
7.4.2 Tuberculosis Prevention and Treatment Vaccine Distributors
7.5 Tuberculosis Prevention and Treatment Vaccine Customers
8 Tuberculosis Prevention and Treatment Vaccine Market Dynamics
8.1 Tuberculosis Prevention and Treatment Vaccine Industry Trends
8.2 Tuberculosis Prevention and Treatment Vaccine Market Drivers
8.3 Tuberculosis Prevention and Treatment Vaccine Market Challenges
8.4 Tuberculosis Prevention and Treatment Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Tuberculosis Prevention and Treatment Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Tuberculosis Prevention and Treatment Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Tuberculosis Prevention and Treatment Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Tuberculosis Prevention and Treatment Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Tuberculosis Prevention and Treatment Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Tuberculosis Prevention and Treatment Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tuberculosis Prevention and Treatment Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tuberculosis Prevention and Treatment Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Tuberculosis Prevention and Treatment Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tuberculosis Prevention and Treatment Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Prevention and Treatment Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Tuberculosis Prevention and Treatment Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Tuberculosis Prevention and Treatment Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tuberculosis Prevention and Treatment Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Tuberculosis Prevention and Treatment Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Tuberculosis Prevention and Treatment Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Tuberculosis Prevention and Treatment Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Tuberculosis Prevention and Treatment Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck Tuberculosis Prevention and Treatment Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Japan BCG Lab Corporation Information
Table 76. Japan BCG Lab Description and Business Overview
Table 77. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product
Table 79. Japan BCG Lab Recent Developments/Updates
Table 80. Serum Institute of India Corporation Information
Table 81. Serum Institute of India Description and Business Overview
Table 82. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product
Table 84. Serum Institute of India Recent Developments/Updates
Table 85. AJ Vaccines Corporation Information
Table 86. AJ Vaccines Description and Business Overview
Table 87. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product
Table 89. AJ Vaccines Recent Developments/Updates
Table 90. BioFarma Corporation Information
Table 91. BioFarma Description and Business Overview
Table 92. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. BioFarma Tuberculosis Prevention and Treatment Vaccine Product
Table 94. BioFarma Recent Developments/Updates
Table 95. GreenSignal Bio Pharma Corporation Information
Table 96. GreenSignal Bio Pharma Description and Business Overview
Table 97. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product
Table 99. GreenSignal Bio Pharma Recent Developments/Updates
Table 100. China National Biotec Corporation Information
Table 101. China National Biotec Description and Business Overview
Table 102. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product
Table 104. China National Biotec Recent Developments/Updates
Table 105. Biomed Lublin Corporation Information
Table 106. Biomed Lublin Description and Business Overview
Table 107. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product
Table 109. Biomed Lublin Recent Developments/Updates
Table 110. Taj Pharmaceuticals Corporation Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product
Table 114. Taj Pharmaceuticals Recent Developments/Updates
Table 115. Ataulpho de Paiva Corporation Information
Table 116. Ataulpho de Paiva Description and Business Overview
Table 117. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product
Table 119. Ataulpho de Paiva Recent Developments/Updates
Table 120. IVAC Corporation Information
Table 121. IVAC Description and Business Overview
Table 122. IVAC Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. IVAC Tuberculosis Prevention and Treatment Vaccine Product
Table 124. IVAC Recent Developments/Updates
Table 125. Queen Saovabha Mem. Inst Corporation Information
Table 126. Queen Saovabha Mem. Inst Description and Business Overview
Table 127. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product
Table 129. Queen Saovabha Mem. Inst Recent Developments/Updates
Table 130. Microgen Corporation Information
Table 131. Microgen Description and Business Overview
Table 132. Microgen Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Microgen Tuberculosis Prevention and Treatment Vaccine Product
Table 134. Microgen Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Tuberculosis Prevention and Treatment Vaccine Distributors List
Table 138. Tuberculosis Prevention and Treatment Vaccine Customers List
Table 139. Tuberculosis Prevention and Treatment Vaccine Market Trends
Table 140. Tuberculosis Prevention and Treatment Vaccine Market Drivers
Table 141. Tuberculosis Prevention and Treatment Vaccine Market Challenges
Table 142. Tuberculosis Prevention and Treatment Vaccine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tuberculosis Prevention and Treatment Vaccine
Figure 2. Global Tuberculosis Prevention and Treatment Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Type in 2023 & 2030
Figure 4. Immune Vaccine Product Picture
Figure 5. Therapy Vaccine Product Picture
Figure 6. Global Tuberculosis Prevention and Treatment Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Application in 2023 & 2030
Figure 8. Self-Procurement
Figure 9. UNICEF
Figure 10. Other
Figure 11. Global Tuberculosis Prevention and Treatment Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Tuberculosis Prevention and Treatment Vaccine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Tuberculosis Prevention and Treatment Vaccine Sales (2019-2030) & (K Units)
Figure 14. Global Tuberculosis Prevention and Treatment Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 15. Tuberculosis Prevention and Treatment Vaccine Report Years Considered
Figure 16. Tuberculosis Prevention and Treatment Vaccine Sales Share by Manufacturers in 2023
Figure 17. Global Tuberculosis Prevention and Treatment Vaccine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Tuberculosis Prevention and Treatment Vaccine Players: Market Share by Revenue in 2023
Figure 19. Tuberculosis Prevention and Treatment Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2019-2030)
Figure 22. North America Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2019-2030)
Figure 23. United States Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2019-2030)
Figure 26. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2019-2030)
Figure 34. China Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2019-2030)
Figure 44. Latin America Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Tuberculosis Prevention and Treatment Vaccine by Type (2019-2030)
Figure 54. Global Revenue Market Share of Tuberculosis Prevention and Treatment Vaccine by Type (2019-2030)
Figure 55. Global Tuberculosis Prevention and Treatment Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Tuberculosis Prevention and Treatment Vaccine by Application (2019-2030)
Figure 57. Global Revenue Market Share of Tuberculosis Prevention and Treatment Vaccine by Application (2019-2030)
Figure 58. Global Tuberculosis Prevention and Treatment Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 59. Tuberculosis Prevention and Treatment Vaccine Value Chain
Figure 60. Tuberculosis Prevention and Treatment Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
